Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

• Theresia M. Westers, Robin Ireland, +36 authors Arjen A. van de Loosdrecht
• Leukemia
• 2012

Flow cytometry (FC) is increasingly recognized as an important tool in the diagnosis and prognosis of myelodysplastic syndromes (MDS). However, validation of current assays and agreement upon the… (More)

High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg®) treatment in acute myeloid leukemia patients

• V. H. J. van der Velden, Nancy Boeckx, +4 authors J J M van Dongen
• Leukemia
• 2004

Gemtuzumab ozogamicin (Mylotarg®) induces remission in approximately 30% of relapsed AML patients. We previously demonstrated that gemtuzumab infusion results in near-complete CD33 saturation in… (More)

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

• V. H. J. van der Velden, A van der Sluijs-Geling, +9 authors J J M van Dongen
• Leukemia
• 2010

Analysis of minimal residual disease (MRD) in childhood acute myeloid leukemia (AML) may predict for clinical outcome. MRD levels were assessed by flowcytometric immunophenotyping in 94 children with… (More)

Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes: testing of a new fixation-permeabilization solution

• EG van Lochem, Kathrin Groeneveld, J G te Marvelde, MWM van den Beemd, Herbert Hooijkaas, J J M van Dongen
• Leukemia
• 1997

Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood

• Anna M. Aalbers, Marry M. van den Heuvel-Eibrink, +15 authors V. H. J. van der Velden
• Leukemia
• 2013

higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na. Leuk Res 2012; 36: 98–103. 10 Chapman CM, Sun X, Roschewski M, Aue G, Farooqui M, Stennett L et… (More)

• ‹
• 1
• ›